From: Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition
Xenograft ID
TNBC subtype
SUTI097
immunomodulatory (IM)
SUTI103
basal-like 1 (BL1)
SUTI110
SUTI151
basal-like 2 (BL2)
SUTI151M
mesenchymal (M)
SUTI319
unstable (UNS)
SUTI368